<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several indices of coagulation and fibrinolysis were studied in 54 patients suffering from Sch√∂nlein-Henoch disease </plain></SENT>
<SENT sid="1" pm="."><plain>A significant prolongation of platelet aggregation was found in parallel with a decrease of AT III and plasminogen and an increase of the fibrin monomer complexes </plain></SENT>
<SENT sid="2" pm="."><plain>Consequent to <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment controlled by measurements of residual thrombin activity, the indices showed a trend towards normalization </plain></SENT>
<SENT sid="3" pm="."><plain>The dynamic monitoring of the above indices can be used for an overall assessment of the <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment </plain></SENT>
</text></document>